{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:18:51Z","timestamp":1784546331871,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science Foundation of Shanghai Health Commission","award":["20204Y0484"],"award-info":[{"award-number":["20204Y0484"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772042"],"award-info":[{"award-number":["81772042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13402-025-01040-1","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T01:22:10Z","timestamp":1744075330000},"page":"693-708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor-specific CXCR6 positive precursor CD8+ T cells mediate tumor control in metastatic melanoma"],"prefix":"10.1007","volume":"48","author":[{"given":"Yang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-5270","authenticated-orcid":false,"given":"Zhiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0873-2831","authenticated-orcid":false,"given":"Yiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"1040_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"S. Valastyan, R.A. Weinberg, Tumor metastasis: molecular insights and evolving paradigms. Cell. 147, 275\u2013292 (2011). https:\/\/doi.org\/10.1016\/j.cell.2011.09.024","journal-title":"Cell"},{"key":"1040_CR2","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"M.E. Dudley et al., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 298, 850\u2013854 (2002). https:\/\/doi.org\/10.1126\/science.1076514","journal-title":"Science"},{"key":"1040_CR3","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1158\/1078-0432.CCR-10-1507","volume":"16","author":"JJ Hong","year":"2010","unstructured":"J.J. Hong et al., Successful treatment of melanoma brain metastases with adoptive cell therapy. Clin. Cancer Res. 16, 4892\u20134898 (2010). https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1507","journal-title":"Clin. Cancer Res."},{"key":"1040_CR4","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","volume":"124","author":"A Gros","year":"2014","unstructured":"A. Gros et al., PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124, 2246\u20132259 (2014). https:\/\/doi.org\/10.1172\/JCI73639","journal-title":"J. Clin. Invest."},{"key":"1040_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.coi.2010.02.005","volume":"22","author":"PS Kim","year":"2010","unstructured":"P.S. Kim, R. Ahmed, Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22, 223\u2013230 (2010). https:\/\/doi.org\/10.1016\/j.coi.2010.02.005","journal-title":"Curr. Opin. Immunol."},{"key":"1040_CR6","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1182\/blood-2013-01-475939","volume":"121","author":"T Zenz","year":"2013","unstructured":"T. Zenz, Exhausting, T cells in CLL. Blood. 121, 1485\u20131486 (2013). https:\/\/doi.org\/10.1182\/blood-2013-01-475939","journal-title":"Blood"},{"key":"1040_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"L.M. McLane, M.S. Abdel-Hakeem, E.J. Wherry, CD8 T cell exhaustion during chronic viral infection and Cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019). https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055318","journal-title":"Annu. Rev. Immunol."},{"key":"1040_CR8","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"S.L. Topalian et al., Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl. J. Med. 366, 2443\u20132454 (2012). https:\/\/doi.org\/10.1056\/NEJMoa1200690","journal-title":"N Engl. J. Med."},{"key":"1040_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fonc.2019.00264","volume":"9","author":"A Addeo","year":"2019","unstructured":"A. Addeo, G.L. Banna, G. Metro, Di M. Maio, Chemotherapy in Combination with Immune Checkpoint inhibitors for the First-Line treatment of patients with Advanced Non-small Cell Lung Cancer: a systematic review and literature-based Meta-analysis. Front. Oncol. 9, 264 (2019). https:\/\/doi.org\/10.3389\/fonc.2019.00264","journal-title":"Front. Oncol."},{"key":"1040_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41591-021-01462-y","volume":"27","author":"BC Creelan","year":"2021","unstructured":"B.C. Creelan et al., Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nat. Med. 27, 1410\u20131418 (2021). https:\/\/doi.org\/10.1038\/s41591-021-01462-y","journal-title":"Nat. Med."},{"key":"1040_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"B.C. Miller et al., Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019). https:\/\/doi.org\/10.1038\/s41590-019-0312-6","journal-title":"Nat. Immunol."},{"issue":"e1044","key":"1040_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"W.H. Hudson et al., Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1(+) stem-like CD8(+) T cells during chronic infection. Immunity. 51(e1044), 1043\u20131058 (2019). https:\/\/doi.org\/10.1016\/j.immuni.2019.11.002","journal-title":"Immunity"},{"key":"1040_CR13","doi-asserted-by":"publisher","unstructured":"J.C. Beltra et al., Developmental Relationships of Four Exhausted CD8(+) T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms. Immunity. 52, 825\u2013841 e828. (2020) https:\/\/doi.org\/10.1016\/j.immuni.2020.04.014","DOI":"10.1016\/j.immuni.2020.04.014"},{"key":"1040_CR14","doi-asserted-by":"publisher","unstructured":"Z. Chen et al., TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision. Immunity. 51, 840\u2013855 e845. (2019) https:\/\/doi.org\/10.1016\/j.immuni.2019.09.013","DOI":"10.1016\/j.immuni.2019.09.013"},{"key":"1040_CR15","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","volume":"21","author":"DT Utzschneider","year":"2020","unstructured":"D.T. Utzschneider et al., Early precursor T cells establish and propagate T cell exhaustion in chronic infection. Nat. Immunol. 21, 1256\u20131266 (2020). https:\/\/doi.org\/10.1038\/s41590-020-0760-z","journal-title":"Nat. Immunol."},{"key":"1040_CR16","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41590-022-01338-4","volume":"23","author":"JR Giles","year":"2022","unstructured":"J.R. Giles et al., Shared and distinct biological circuits in effector, memory and exhausted CD8(+) T cells revealed by temporal single-cell transcriptomics and epigenetics. Nat. Immunol. 23, 1600\u20131613 (2022). https:\/\/doi.org\/10.1038\/s41590-022-01338-4","journal-title":"Nat. Immunol."},{"issue":"e110","key":"1040_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"I. Siddiqui et al., Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like Properties promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy. Immunity. 50(e110), 195\u2013211 (2019). https:\/\/doi.org\/10.1016\/j.immuni.2018.12.021","journal-title":"Immunity"},{"key":"1040_CR18","doi-asserted-by":"publisher","unstructured":"S. Kurtulus et al., Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1(-)CD8(+) Tumor-Infiltrating T Cells. Immunity 50, 181\u2013194 e186. https:\/\/doi.org\/10.1016\/j.immuni.2018.11.014 (2019)","DOI":"10.1016\/j.immuni.2018.11.014"},{"key":"1040_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-4614-8244-4_10","volume":"1070","author":"R Giavazzi","year":"2014","unstructured":"R. Giavazzi, A. Decio, Syngeneic murine metastasis models: B16 melanoma. Methods Mol. Biol. 1070, 131\u2013140 (2014). https:\/\/doi.org\/10.1007\/978-1-4614-8244-4_10","journal-title":"Methods Mol. Biol."},{"key":"1040_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature19317","volume":"537","author":"R He","year":"2016","unstructured":"R. He et al., Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 537, 412\u2013428 (2016). https:\/\/doi.org\/10.1038\/nature19317","journal-title":"Nature"},{"key":"1040_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"S.J. Im et al., Defining CD8\u2009+\u2009T cells that provide the proliferative burst after PD-1 therapy. Nature. 537, 417\u2013421 (2016). https:\/\/doi.org\/10.1038\/nature19330","journal-title":"Nature"},{"key":"1040_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ni.3543","volume":"17","author":"YA Leong","year":"2016","unstructured":"Y.A. Leong et al., CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat. Immunol. 17, 1187\u20131196 (2016). https:\/\/doi.org\/10.1038\/ni.3543","journal-title":"Nat. Immunol."},{"key":"1040_CR23","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"J. Brummelman et al., High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors. J. Exp. Med. 215, 2520\u20132535 (2018). https:\/\/doi.org\/10.1084\/jem.20180684","journal-title":"J. Exp. Med."},{"key":"1040_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"J.M. Ubellacker et al., Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 585, 113\u2013118 (2020). https:\/\/doi.org\/10.1038\/s41586-020-2623-z","journal-title":"Nature"},{"key":"1040_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00262-019-02330-y","volume":"68","author":"J Rotman","year":"2019","unstructured":"J. Rotman, B.D. Koster, E.S. Jordanova, A.M. Heeren, de Gruijl, T. D. Unlocking the therapeutic potential of primary tumor-draining lymph nodes. Cancer Immunol. Immunother. 68, 1681\u20131688 (2019). https:\/\/doi.org\/10.1007\/s00262-019-02330-y","journal-title":"Cancer Immunol. Immunother"},{"key":"1040_CR26","doi-asserted-by":"publisher","unstructured":"F. Dammeijer et al., The PD-1\/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes. Cancer Cell 38, 685\u2013700 e688. https:\/\/doi.org\/10.1016\/j.ccell.2020.09.001 (2020)","DOI":"10.1016\/j.ccell.2020.09.001"},{"key":"1040_CR27","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"J.R. Giles, A.M. Globig, S.M. Kaech, E.J. Wherry, CD8(+) T cells in the cancer-immunity cycle. Immunity. 56, 2231\u20132253 (2023). https:\/\/doi.org\/10.1016\/j.immuni.2023.09.005","journal-title":"Immunity"},{"key":"1040_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41568-023-00615-0","volume":"23","author":"T Gebhardt","year":"2023","unstructured":"T. Gebhardt, S.L. Park, I.A. Parish, Stem-like exhausted and memory CD8(+) T cells in cancer. Nat. Rev. Cancer. 23, 780\u2013798 (2023). https:\/\/doi.org\/10.1038\/s41568-023-00615-0","journal-title":"Nat. Rev. Cancer"},{"key":"1040_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.immuni.2007.08.007","volume":"27","author":"SM Kaech","year":"2007","unstructured":"S.M. Kaech, E.J. Wherry, Heterogeneity and cell-fate decisions in effector and memory CD8\u2009+\u2009T cell differentiation during viral infection. Immunity. 27, 393\u2013405 (2007). https:\/\/doi.org\/10.1016\/j.immuni.2007.08.007","journal-title":"Immunity"},{"key":"1040_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nri2251","volume":"8","author":"JT Harty","year":"2008","unstructured":"J.T. Harty, V.P. Badovinac, Shaping and reshaping CD8\u2009+\u2009T-cell memory. Nat. Rev. Immunol. 8, 107\u2013119 (2008). https:\/\/doi.org\/10.1038\/nri2251","journal-title":"Nat. Rev. Immunol."},{"key":"1040_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Y. Simoni et al., Bystander CD8(+) T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature. 557, 575\u2013579 (2018). https:\/\/doi.org\/10.1038\/s41586-018-0130-2","journal-title":"Nature"},{"key":"1040_CR32","doi-asserted-by":"publisher","first-page":"328rv324","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"W. Zou, J.D. Wolchok, L. Chen, PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl Med. 8, 328rv324 (2016). https:\/\/doi.org\/10.1126\/scitranslmed.aad7118","journal-title":"Sci. Transl Med."},{"key":"1040_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fimmu.2020.00339","volume":"11","author":"Y Jiang","year":"2020","unstructured":"Y. Jiang, X. Zhao, J. Fu, H. Wang, Progress and challenges in Precise Treatment of Tumors with PD-1\/PD-L1 blockade. Front. Immunol. 11, 339 (2020). https:\/\/doi.org\/10.3389\/fimmu.2020.00339","journal-title":"Front. Immunol."},{"key":"1040_CR34","doi-asserted-by":"publisher","unstructured":"Di M. Pilato et al., CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell 184, 4512\u20134530 e4522. https:\/\/doi.org\/10.1016\/j.cell.2021.07.015 (2021)","DOI":"10.1016\/j.cell.2021.07.015"},{"key":"1040_CR35","doi-asserted-by":"publisher","unstructured":"A.K. Molodtsov et al., Resident memory CD8(+) T cells in regional lymph nodes mediate immunity to metastatic melanoma. Immunity 54, 2117\u20132132 e2117. https:\/\/doi.org\/10.1016\/j.immuni.2021.08.019 (2021)","DOI":"10.1016\/j.immuni.2021.08.019"},{"key":"1040_CR36","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"D.R. Sen et al., The epigenetic landscape of T cell exhaustion. Science. 354, 1165\u20131169 (2016). https:\/\/doi.org\/10.1126\/science.aae0491","journal-title":"Science"},{"key":"1040_CR37","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"K.E. Pauken et al., Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science. 354, 1160\u20131165 (2016). https:\/\/doi.org\/10.1126\/science.aaf2807","journal-title":"Science"},{"key":"1040_CR38","doi-asserted-by":"publisher","unstructured":"J. Korbecki et al., The role of CXCL16 in the pathogenesis of Cancer and Other diseases. Int. J. Mol. Sci. 22 (2021). https:\/\/doi.org\/10.3390\/ijms22073490","DOI":"10.3390\/ijms22073490"},{"key":"1040_CR39","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.4049\/jimmunol.164.11.5761","volume":"164","author":"DD Pinschewer","year":"2000","unstructured":"D.D. Pinschewer et al., FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J. Immunol. 164, 5761\u20135770 (2000). https:\/\/doi.org\/10.4049\/jimmunol.164.11.5761","journal-title":"J. Immunol."},{"key":"1040_CR40","doi-asserted-by":"publisher","first-page":"21453","DOI":"10.1074\/jbc.C200176200","volume":"277","author":"V Brinkmann","year":"2002","unstructured":"V. Brinkmann et al., The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453\u201321457 (2002). https:\/\/doi.org\/10.1074\/jbc.C200176200","journal-title":"J. Biol. Chem."},{"key":"1040_CR41","doi-asserted-by":"publisher","first-page":"eabg7836","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"K.A. Connolly et al., A reservoir of stem-like CD8(+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 (2021). https:\/\/doi.org\/10.1126\/sciimmunol.abg7836","journal-title":"Sci. Immunol."},{"key":"1040_CR42","doi-asserted-by":"publisher","unstructured":"J.M. Schenkel et al., Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1(+) CD8(+) T cells in tumor-draining lymph nodes. Immunity. 54, 2338\u20132353 e2336. (2021) https:\/\/doi.org\/10.1016\/j.immuni.2021.08.026","DOI":"10.1016\/j.immuni.2021.08.026"},{"key":"1040_CR43","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"M.A. Paley et al., Progenitor and terminal subsets of CD8\u2009+\u2009T cells cooperate to contain chronic viral infection. Science. 338, 1220\u20131225 (2012). https:\/\/doi.org\/10.1126\/science.1229620","journal-title":"Science"},{"key":"1040_CR44","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/jvi.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"E.J. Wherry, J.N. Blattman, K. Murali-Krishna, van der R. Most, R. Ahmed, Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911\u20134927 (2003). https:\/\/doi.org\/10.1128\/jvi.77.8.4911-4927.2003","journal-title":"J. Virol."},{"key":"1040_CR45","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1128\/JVI.01579-09","volume":"84","author":"SD Blackburn","year":"2010","unstructured":"S.D. Blackburn et al., Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J. Virol. 84, 2078\u20132089 (2010). https:\/\/doi.org\/10.1128\/JVI.01579-09","journal-title":"J. Virol."},{"key":"1040_CR46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"S.L. Topalian, C.G. Drake, D.M. Pardoll, Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 27, 450\u2013461 (2015). https:\/\/doi.org\/10.1016\/j.ccell.2015.03.001","journal-title":"Cancer Cell."},{"key":"1040_CR47","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"A. Ribas, J.D. Wolchok, Cancer immunotherapy using checkpoint blockade. Science. 359, 1350\u20131355 (2018). https:\/\/doi.org\/10.1126\/science.aar4060","journal-title":"Science"},{"key":"1040_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature24462","volume":"551","author":"VP Balachandran","year":"2017","unstructured":"V.P. Balachandran et al., Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature. 551, 512\u2013516 (2017). https:\/\/doi.org\/10.1038\/nature24462","journal-title":"Nature"},{"key":"1040_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1302369","volume":"369","author":"JD Wolchok","year":"2013","unstructured":"J.D. Wolchok et al., Nivolumab plus Ipilimumab in advanced melanoma. N Engl. J. Med. 369, 122\u2013133 (2013). https:\/\/doi.org\/10.1056\/NEJMoa1302369","journal-title":"N Engl. J. Med."},{"key":"1040_CR50","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"T. Yokosuka et al., Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209, 1201\u20131217 (2012). https:\/\/doi.org\/10.1084\/jem.20112741","journal-title":"J. Exp. Med."},{"key":"1040_CR51","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","volume":"355","author":"E Hui","year":"2017","unstructured":"E. Hui et al., T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science. 355, 1428\u20131433 (2017). https:\/\/doi.org\/10.1126\/science.aaf1292","journal-title":"Science"},{"key":"1040_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"M. Philip et al., Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature. 545, 452\u2013456 (2017). https:\/\/doi.org\/10.1038\/nature22367","journal-title":"Nature"},{"key":"1040_CR53","doi-asserted-by":"publisher","unstructured":"H.E. Ghoneim et al., De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation. Cell. 170, 142\u2013157 e119. (2017) https:\/\/doi.org\/10.1016\/j.cell.2017.06.007","DOI":"10.1016\/j.cell.2017.06.007"},{"key":"1040_CR54","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"A. Emadi, R.J. Jones, R.A. Brodsky, Cyclophosphamide and cancer: golden anniversary. Nat. Rev. Clin. Oncol. 6, 638\u2013647 (2009). https:\/\/doi.org\/10.1038\/nrclinonc.2009.146","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01040-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T05:25:48Z","timestamp":1748409948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01040-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1040"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01040-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4628675\/v1","asserted-by":"object"}]},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"16 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse experiments were performed in accordance with the guidelines of the Department of Laboratory Animal Science of the Fudan University (Approval Number: 2024-HSYY-716).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}